Loading...

PE/Cyanine7 anti-human CD45 Antibody

Pricing & Availability
Clone
HI30 (See other available formats)
Regulatory Status
RUO
Workshop
IV N816
Other Names
LCA, T200
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
HI30_PECy7_071307
Human peripheral blood lymphocytes stained with HI30 PE/Cyanine7
  • HI30_PECy7_071307
    Human peripheral blood lymphocytes stained with HI30 PE/Cyanine7
See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
304015 25 tests £98
Check Availability


Need larger quantities of this item?
Request Bulk Quote
304016 100 tests £194
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD single chain type I membrane glycoprotein also known as leukocyte common antigen (LCA) and T200. It is a tyrosine phosphatase expressed on the plasma membrane of all hematopoietic cells, except erythrocytes and platelets. CD45 is a signaling molecule that regulates a variety of cellular processes including cell growth, differentiation, cell cycle, and oncogenic transformation. CD45 plays a critical role in T and B cell antigen receptor-mediated activation by dephosphorylating substrates including p56Lck, p59Fyn, and other Src family kinases. CD45 non-covalently associates with lymphocyte phosphatase-associated phosphoprotein (LPAP) on T and B lymphocytes. CD45 has been reported to bind galectin-1 and to be associated with several other cell surface antigens including CD1, CD2, CD3, and CD4.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections and formalin-fixed paraffin-embedded tissue sections9, inhibition of CD45 functions4, immunofluorescence11, Western blotting3, and spatial biology (IBEX)16,17.

It was found that the HI30 clone and the 2D1 clone can cross block each other's binding.

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  2. Kishihara K, et al. 1993. Cell 74:143.
  3. Esser M, et al. 2001. J. Virol. 75:6173. (WB)
  4. Yamada T, et al. 2002. J. Biol. Chem. 277:28830.
  5. Nagano M, et al. 2007. Blood 110:151.
  6. Jiang Q, et al. 2008. Blood 112:2858. PubMed
  7. Morozov A, et al. 2010. Clin Cancer Res. 16:5630. PubMed
  8. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  9. Friedman T, et al. 1999. J. Immunol. 162:5256. (IHC)
  10. Oeztuerk-Winder F, et al. 2012. EMBO J. 31:3431. (FC) PubMed
  11. Rees LE, et al. 2003. Clin. Exp. Immunol. 134:497. (IF)
  12. Lee J, et al. 2015. J Exp Med. 212:385. PubMed
  13. Breton G, et al. 2015. J Exp Med. 212:401. PubMed
  14. Marquardt N, et al. 2015. J Immunol. 6:2467. PubMed
  15. Bushway ME, et al. 2014. Biol Reprod. 90(5): 110. (IF) PubMed
  16. Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed
  17. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Bravo-Flores E, et al. 2018. Int J Mol Sci. 19:E1074. PubMed
  2. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  3. Charmsaz S, et al. 2017. Leukemia. 31:1779. PubMed
  4. Sugden SM, et al. 2017. J Virol. 91:e02445. PubMed
  5. Linedale R, et al. 2017. PLoS One. 12:e0175755. PubMed
  6. Suzuki D, et al. 2020. Stem Cell Reports. 14:49. PubMed
  7. Li J, et al. 2017. Toxicology. 378:17. PubMed
  8. Brown CC, et al. 2020. Cell. 179(4):846-863.e24.. PubMed
  9. Palpant N, et al. 2013. Development. 140:3799. PubMed
  10. Li L, et al. 2014. Stem Cells Trans Med. 3:1199. PubMed
  11. Bhatwadekar A, et al. 2015. Diabetes. 64: 4226 - 4237. PubMed
  12. Vishnoi M, et al. 2015. Sci Rep. 5: 17533. PubMed
  13. Cordeiro O, et al. 2016. PLoS One. 11: 0151848. PubMed
  14. Pecht T, et al. 2016. PLoS One. 11: 0159350. PubMed
  15. P, et al. 2016. Mol Ther. 24: 1602-1614. PubMed
  16. Pierini S, et al. 2020. JCI Insight. 5:00. PubMed
  17. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  18. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  19. Liu X, et al. 2021. iScience. 24(6):102551. PubMed
  20. Aung A, et al. 2020. Cancer Res. 80:263. PubMed
  21. Hohmann MS, et al. 2021. JCI Insight. 6:. PubMed
  22. Brito-Pérez Y, et al. 2021. Immun Inflamm Dis. 9:1541. PubMed
  23. Che LH, et al. 2021. Cell Discov. 7:80. PubMed
  24. Bhargavan B, et al. 2021. Mol Neurodegener. 16:78. PubMed
  25. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  26. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  27. Higham A, et al. 2021. Cells. 11:. PubMed
  28. Moquin-Beaudry G, et al. 2022. Cell Rep Methods. 2:100153. PubMed
  29. Wong HY, et al. 2022. Nat Commun. 13:6036. PubMed
  30. Liang J, et al. 2022. J Clin Invest. 132: . PubMed
  31. Omer-Javed A, et al. 2022. Cell. 185:2248. PubMed
  32. Gur C, et al. 2022. Cell. 185:1373. PubMed
  33. Woodcock V, et al. 2023. BJUI Compass. 4:322. PubMed
RRID
AB_314403 (BioLegend Cat. No. 304015)
AB_314404 (BioLegend Cat. No. 304016)

Antigen Details

Structure
Tyrosine phosphatases, type I transmembrane protein, 180-240 kD (multiple isoforms)
Distribution

Hematopoietic cells, not expressed in circulating erythrocytes or platelets

Function
TCR and BCR mediated activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
Hematopoietic stem and progenitors, Mesenchymal Stem Cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References
  1. Thomas M. 1989. Annu. Rev. Immunol. 7:339.
  2. Trowbridge I, et al. 1994. Annu. Rev. Immunol.12:85.
Gene ID
5788 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org
Go To Top Version: 2    Revision Date: 04/25/2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account